While autologous CAR T-cell therapies have revolutionized the treatment of hematologic malignancies, their widespread application is hindered by manufacturing complexities, high costs, and limited ...

From the advent of new innovations to shifting care models, healthcare leaders reflect on what words and trends will define the spine surgery field in 2026. The 23 leaders featured in this article are ...

Washington, DC, February 27, 2025-New orders for manufactured durable goods in January, up following two consecutive monthly decreases, increased $8.7 billion or 3.1% to $286.0 billion, the U.S.

Cloud security architect and advisor Steven Smiley walked attendees through a slate of notable AWS announcements in a Virtualization & Cloud Review webcast today. The presentation held by Smiley, an ...

– Initial Results from Kite-753, Optimized with Novel Manufacturing Process That Preserves T-Cell Fitness, Show High Complete Response Rate and Favorable Safety Trend – – Novel Construct for Two ...

Kite’s Next-Generation Bicistronic CAR T-Cell Therapies Show Encouraging Phase 1 Results in Relapsed/Refractory B-Cell Lymphoma in New Data at ASH 2025 – Initial Results from Kite-753, Optimized with ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

As infrastructure ages, one question shapes the future of cities: How do we know the materials we build with will last? At the University of Miami College of Engineering, Prannoy Suraneni, associate ...

The Fastapi version of the python sdk is strictly set between 0.115.0 < 0.116.0. This makes managing dependencies in projects harder. Loosening it at least up to < 0.117.0 would help. According to ...

A major challenge for mRNA-based vaccines and therapeutics is the limited stability of mRNA in vivo. Viruses offer a promising source of RNA-stabilizing elements, but those identified so far are ...

Week 16 follow-up data, coupled with blinded exit interviews conducted up to 364 days after the study period, confirm durable and wide-ranging upper and lower-body improvements compared to placebo ...